$EOLS
Evolus, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
$8.01
▲+0.00%+$0.000
Subscriptions are live. Early access $24.99/mo, or start with 5 free premium days.
Plans & pricingDonateEvolus, Inc. Common Stock
XNAS•Health Care•Pharmaceutical Preparations
Why is EOLS up today? It is at $8.01 (+0.00%), and our scanner flagged it 48 times on unusual volume this month. See the catalyst behind the move, real-time alerts the moment EOLS spikes, and full due diligence on EOLS — key stats, earnings, dilution and insider activity. Free.
Our scanner flagged $EOLS 48 times in the last 30 days. Create a free account to track $EOLS, build a watchlist, and get instant unusual-volume alerts, with a full day of premium now and 5 more when you verify your email, no card needed.
No card · 5 premium days · join 800+ traders
The top plays and unusual-volume catches our scanner flags, emailed to you. No account needed.
No spam. Unsubscribe anytime. Not investment advice.
Here is the latest on EOLS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EOLS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
| Insider | Action | Shares | % of position | Owns after | Value | Date |
|---|---|---|---|---|---|---|
Moatazedi David Officer | Sold (automatic/other) | -105K 0.2% of company | sold 17% | 500K | $950K at $9.04 | Sep 2, 26 |
Moatazedi David Officer | Sold (automatic/other) | -14K 0.02% of company | sold 2.2% | 605K | $65K at $4.75 | Mar 20, 26 |
Avelar Rui Officer | Sold (automatic/other) | -3K | sold 0.7% | 427K | $15K at $4.75 | Mar 20, 26 |
Moatazedi David Officer | Sold (automatic/other) | -117K 0.2% of company | sold 16% | 618K | $571K at $4.89 | Mar 17, 26 |
Avelar Rui Officer | Sold (automatic/other) | -30K 0.05% of company | sold 6.5% | 431K | $147K at $4.89 | Mar 17, 26 |
Avelar Rui Officer | Other | 9K 0.01% of company | added 1.9% | 461K | n/a | Mar 16, 26 |
Moatazedi David Officer | Other | 67K 0.1% of company | added 10% | 735K | n/a | Mar 16, 26 |
Avelar Rui Officer | Acquired (grant/award) | +95K 0.1% of company | added 27% | 452K | n/a | Feb 17, 26 |
Gill David N Director | Acquired (grant/award) | +46K 0.07% of company | added 100% | 87K | n/a | Feb 17, 26 |
Moatazedi David Officer | Acquired (grant/award) | +313K 0.5% of company | added 88% | 668K | n/a | Feb 17, 26 |
Malik Vikram Director | Acquired (grant/award) | +46K 0.07% of company | added 17% | 321K | n/a | Feb 17, 26 |
Mitchell Tatjana Officer | Acquired (grant/award) | +121K 0.2% of company | added 100% | 226K | n/a | Feb 17, 26 |
Recent Form-4 filings via Nasdaq. Open-market buys are the signal worth watching. Grants and automatic (10b5-1) sells are routine. “% of position” is the share of that insider’s own holding the trade moved. Not investment advice.
Blend of news sentiment, today’s move, and community votes. Not investment advice.
News, unusual-volume alerts, AI-trader trades and community chatter - the whole story, newest first.
Comparable names in pharmaceutical preparations, closest in size first.
Here is the latest on EOLS from our scanner (live price and day move above). We have not detected an unusual-volume catalyst for EOLS today, so it is trading in line with its recent range. The moment our scanner flags unusual activity, the reason will appear here.
EOLS last traded at $8.01, up 0.00% on the day. The price and chart above update live during market hours (4 AM to 8 PM ET).
Evolus, Inc. Common Stock (EOLS) is next expected to report earnings on Wednesday, November 4, 2026, about 47 days away. Earnings reports often cause large overnight gaps, so many traders manage risk around the date. The date can shift until the company officially confirms it.
The EOLS Live Alerts panel on this page streams real-time unusual volume (RVOL), momentum, halt and 200-EMA alerts from our scanner the moment they fire. Our scanner has flagged EOLS 48 times in the last 30 days.
EOLS (Evolus, Inc. Common Stock) trades on XNAS, with a market cap of about $528M in the Pharmaceutical Preparations sector.
That depends on your strategy and risk. Day traders look for volume, volatility and a clear trend. Use the live chart, RVOL alerts and 200-EMA context on this page to judge EOLS for yourself. This is not investment advice.
Live data from TheDesperateTrader scanner. Not investment advice.
$EOLS discussion
Sign in to ask a question or join the discussion.